All Articles on COVID-19 Vaccine

• 
  KPWHRI joins NIAID-sponsored study evaluating second COVID-19 booster shots

  Study includes multiple variant vaccines.
• 
  Volunteers needed for expanded COVID-19 booster trial

  New arm of NIAID-sponsored mix-and-match trial will look at Novavax protein vaccine.
• 
  Volunteers needed for COVID-19 booster trial

  NIAID-sponsored study includes Seattle in test for benefits of mixing different vaccine types.
• 
  NIH-Moderna COVID-19 vaccine receives FDA Emergency Use Authorization

  The investigational vaccine that KPWHRI’s team first tested shows an efficacy rate of about 94% as research continues.
• 
  The next stage in COVID-19 vaccine research

  In a Viewpoint for JAMA, KPWHRI’s Dr. Mike Jackson plans ahead to meet the challenges of continuing to evaluate new vaccines.